0001596771-19-000083.txt : 20190726
0001596771-19-000083.hdr.sgml : 20190726
20190726162440
ACCESSION NUMBER: 0001596771-19-000083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190724
FILED AS OF DATE: 20190726
DATE AS OF CHANGE: 20190726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KOUSKY KENNETH W
CENTRAL INDEX KEY: 0000939478
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 19978313
MAIL ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gemphire Therapeutics Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
BUSINESS PHONE: 248-980-6538
MAIL ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-07-24
0
0001638287
Gemphire Therapeutics Inc.
GEMP
0000939478
KOUSKY KENNETH W
17199 N. LAUREL PARK DRIVE
SUITE 401
LIVONIA
MI
48152
1
0
0
0
Common Stock
2019-07-24
4
A
0
15000
0
A
26935
D
4,472 shares previously held by the BWA Gemphire Investment Group, LLC, and 6,463 shares previously held by BWA Gemphire Investment Group II, LLC were transferred to Mr. Kousky and are now held directly.
/s/ Stephanie Swan, by Power of Attorney
2019-07-26